Use of angiotensin II receptor antagonists for treating acute myocardial infarction
AssigneeNovartis AG
InventorsJessica M. Mann, Pascale Oddou, Eric Michel Neuhart
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of an angiotensin II receptor antagonist or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of acute MI and for the secondary prevention of acute MI.
Claims9
Use of an angiotensin II receptor antagonist or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of acute myocardial infarction (MI) and for the secondary prevention of acute MI.
A pharmaceutical combination for the treatment of acute MI and for the secondary prevention of acute MI comprising an AT1 receptor blocker and an other accepted active ingredient for the treatment of acute and chronic phases of myocardial infarction selected from the group consisting of an ACE inhibitor, a beta-blocker and aspirin, or, in each case, a pharmaceutically accetable salt thereof in admixture with a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.